Mathematical efficacy modeling supports this conclusion
Side effects: Depending on the dose, there are lower rates of diarrhea but higher rates of nausea and vomiting compared to semaglutide
The injection is once per week
To identify yours: Check your insurance card for plan/group identifiers Log in to caremark.com and use the formulary lookup tool Request a Summary Plan Description (SPD) or Evidence of Coverage (EOC) from your employer or insurer Call Caremark member services using the number on your card Ask your prescriber's office to verify formulary status before submitting PA The template determines which GLP-1 medications are preferred, what step therapy applies, and what PA criteria your specific plan uses
Saxenda Pancreatic Cancer Lawsuits Emerge In December 2024, plaintiffs argue that the weight loss drug, Saxenda, put them at risk of developing pancreatic cancer, citing adverse reactions to the glucagon-like peptide 1 receptor agonists
The financial picture between these two compounds is vastly different right now, and that difference will persist even after retatrutide gains approval